BNT324

PreclinicalSmall molecule

BioNTech

BNT324 is one of 2 small molecule programs targeting Advanced Lung Cancer. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Advanced Lung CancerRecruiting

Advanced Lung CancerPreclinical

Recruiting

Competition

Competitive Landscape

1 competitor in Advanced Lung Cancer

#DrugCompanyPhaseTrials

BNT327

BioNTech

Preclinical

1 2

BNT324

BioNTech

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q1 2031

Phase 3Recruiting

Metastatic Castration-Resistant Prostate Cancer

NCT07365995

Q2 2032

PreclinicalRecruiting

Advanced Lung Cancer

NCT06892548

Clinical

Trials by Indication[1]

Metastatic Castration-Resistant Prostate Cancer1 trial

A Phase III, Randomized, Open-label Trial of BNT324 Versus Docetaxel With Prednisone/Prednisolone in Metastatic Castration-resistant Prostate Cancer

Recruiting· BioNTech logo

BioNTech·Phase 3·NCT07365995·736 enrolled

Advanced Lung Cancer1 trial

A Phase Ib/II, Multi-site, Open-label, Two-part Trial to Evaluate the Efficacy, Safety, Pharmacokinetics, and Recommended Combination Dose of BNT324 With BNT327 in Participants With Advanced Lung Cancer

Recruiting· BioNTech logo

BioNTech·Preclinical·NCT06892548·594 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for BNT324. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — BNT324 compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for BNT324. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — BioNTech company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: BioNTech

BNT324

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q1 2031

Q2 2032

Trials by Indication[1]

Metastatic Castration-Resistant Prostate Cancer1 trial

Advanced Lung Cancer1 trial

References

Drug Info

Quick Facts

Related News